Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,560,437,127
+$326,399,883 QoQ
Shares Held
10,474,706
-3.0% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.81196722848355.ToString("F0")%
Shared 0.46914920571517715.ToString("F0")%
None 1.7188835658012742.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $19,026,917,368 across 16 Drug Manufacturers - General names. JNJ ranks #4 (13.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,471,778 | $4,113,007,243 | |
| 2 | AZN |
Astrazeneca PLC
|
17,792,161 | $3,508,969,981 | |
| 3 | ABBV |
AbbVie Inc.
|
14,552,069 | $3,164,929,479 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
10,474,706 | $2,560,437,127 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,267,205 | $1,956,782,081 | |
| 6 | PFE |
Pfizer Inc
|
28,341,834 | $795,838,692 | |
| 7 | NVO |
Novo Nordisk A S
|
16,083,479 | $591,067,849 | |
| 8 | AMGN |
Amgen Inc
|
1,500,535 | $527,963,233 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,560,437,127 | 10,474,706 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,234,037,244 | 10,795,058 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,992,215,427 | 16,137,501 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,666,927,161 | 17,459,425 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,944,762,662 | 17,756,649 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,521,501,612 | 17,435,359 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,729,101,578 | 16,840,069 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,208,592,771 | 15,110,788 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,970,965,293 | 12,459,481 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,718,742,653 | 10,965,565 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,807,648,201 | 11,606,088 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,087,973,387 | 12,614,629 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,898,848,890 | 12,250,638 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,179,971,575 | 12,340,626 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,030,970,909 | 12,432,486 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,519,717,877 | 14,194,794 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,731,764,196 | 15,413,667 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,799,066,152 | 16,362,110 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,647,344,496 | 16,392,226 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,655,323,631 | 16,118,269 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,287,836,140 | 13,920,512 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,336,428,064 | 14,845,775 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,072,442,795 | 13,920,223 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,735,734,348 | 12,342,561 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,639,304,382 | 12,501,368 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||